Similar articles

• Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis.

  Hamann CR, Thyssen JP. Hamann CR, et al. J Am Acad Dermatol. 2018 Mar;78(3 Suppl 1):S37-S42. doi: 10.1016/j.jaad.2017.12.018. Epub 2017 Dec 15. J Am Acad Dermatol. 2018. PMID: 29248521 Review.
• Effects of Merino Wool on Atopic Dermatitis Using Clinical, Quality of Life, and Physiological Outcome Measures.

  Fowler JF Jr, Fowler LM, Lorenz D. Fowler JF Jr, et al. Dermatitis. 2019 May/Jun;30(3):198-206. doi: 10.1097/DER.0000000000000449. Dermatitis. 2019. PMID: 30864970 Free PMC article.
• Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

  Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Suárez-Fariñas M, Hager MD, Stahl N, Yancopoulos GD, Radin AR. Beck LA, et al. N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768. N Engl J Med. 2014. PMID: 25006719 Clinical Trial.
• Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

  Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Clinical Trial.
• Assessing the severity of atopic dermatitis in clinical trials and practice.

  Chopra R, Silverberg JI. Chopra R, et al. Clin Dermatol. 2018 Sep-Oct;36(5):606-615. doi: 10.1016/j.clindermatol.2018.05.012. Epub 2018 Jun 1. Clin Dermatol. 2018. PMID: 30217273 Review.